Emgality was specifically developed to help prevent future migraine days
If you have 4 or more migraine days a month, ask your doctor about Emgality
Emgality is a prescription medicine used for the preventive treatment of migraine in adults.
Select Safety Information
Do not use Emgality if you are allergic to galcanezumab-gnlm or any of the ingredients in Emgality.
Experience Emgality for as little as $0 for up to 12 months if you’re eligible and commercially insured*
To do this, we will need your HIPAA† authorization to work on your behalf to help you pay as little as possible. Requesting an Emgality savings card shouldn’t take more than a few minutes.
*Terms and Conditions:
Offer good until 12/31/2021 for up to 12 months of Emgality. Patients with commercial drug insurance may be able to pay as little as $0 for their first fill of Emgality. For the 2nd and subsequent fills, patients must have coverage for Emgality through their commercial drug insurance plan to continue to pay as little as $0 per fill. Offer subject to a monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges and a separate $4900 maximum annual savings. Participation in the program requires a valid patient HIPAA authorization. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for patients without commercial drug insurance or those whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DOD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found here.
†As a reminder, HIPAA is the Health Insurance Portability and Accountability Act that provides data privacy and security to protect your health information.
Emgality can help give you more migraine-free days
In people who had 4-14 migraine days per month,
Emgality is the first CGRP antagonist with:
For patients with 15+ headache days per month, the Emgality label includes data for ≥50% reduction in monthly migraine headache days but does not include data for ≥75% or 100% reduction in monthly migraine headache days.
Make an appointment with your primary care doctor or neurologist today
Select Safety Information
Emgality may cause allergic reactions, such as itching, rash, hives, and trouble breathing. Allergic reactions can happen days after using Emgality. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms, which may be part of an allergic reaction:
- swelling of your face, mouth, tongue, or throat
- trouble breathing